国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2009年
12期
7-10
,共4页
氟伐他汀%缺血性脑卒中%疗效%护理
氟伐他汀%缺血性腦卒中%療效%護理
불벌타정%결혈성뇌졸중%료효%호리
Fluvastatin%Cerebral arterial thrombosis%Effect%Nursing
目的 观察不同剂量氟伐他汀对缺血性脑卒中患者的治疗效果并初步总结治疗中的护理措施.方法 将85例缺血性脑卒中患者随机分为3组,组①为空白组,组②为常规剂量治疗组,组③为大剂量强化治疗组,进行相关的治疗和护理.于治疗前及治疗4周、12周、24周检测血脂;治疗前和治疗24周时,用德国SEQUOIAS-512型B超测定颈动脉内膜-中层厚度(IMT);记录治疗中出现的副作用等进行比较.结果 患者治疗4周、12周、24周血脂试验发现,两个试验组中的LDL、TC、TG下降与空白组比较均有统计学意义(P<0.05);在治疗24周后,两个试验组可使颈动脉内膜-中层厚度减少(P<0.05);而且,氟伐他汀的副作用较少,3组间的差异没有统计学意义(P>0.05).结论 不同剂量氟伐他汀对缺血性脑卒中患者的疗效明显不同,越大剂量的氟伐他汀对缺血性脑卒中患者的LDL-L、TC降低作用越明显、对颈动脉粥样硬化发展的抑制作用就越大,且副作用未见增加.良好的护理,能使患者保持较好的用药依从性、及早发现药物的副作用,从而保证治疗的顺利进行,促进患者早日康复.
目的 觀察不同劑量氟伐他汀對缺血性腦卒中患者的治療效果併初步總結治療中的護理措施.方法 將85例缺血性腦卒中患者隨機分為3組,組①為空白組,組②為常規劑量治療組,組③為大劑量彊化治療組,進行相關的治療和護理.于治療前及治療4週、12週、24週檢測血脂;治療前和治療24週時,用德國SEQUOIAS-512型B超測定頸動脈內膜-中層厚度(IMT);記錄治療中齣現的副作用等進行比較.結果 患者治療4週、12週、24週血脂試驗髮現,兩箇試驗組中的LDL、TC、TG下降與空白組比較均有統計學意義(P<0.05);在治療24週後,兩箇試驗組可使頸動脈內膜-中層厚度減少(P<0.05);而且,氟伐他汀的副作用較少,3組間的差異沒有統計學意義(P>0.05).結論 不同劑量氟伐他汀對缺血性腦卒中患者的療效明顯不同,越大劑量的氟伐他汀對缺血性腦卒中患者的LDL-L、TC降低作用越明顯、對頸動脈粥樣硬化髮展的抑製作用就越大,且副作用未見增加.良好的護理,能使患者保持較好的用藥依從性、及早髮現藥物的副作用,從而保證治療的順利進行,促進患者早日康複.
목적 관찰불동제량불벌타정대결혈성뇌졸중환자적치료효과병초보총결치료중적호리조시.방법 장85례결혈성뇌졸중환자수궤분위3조,조①위공백조,조②위상규제량치료조,조③위대제량강화치료조,진행상관적치료화호리.우치료전급치료4주、12주、24주검측혈지;치료전화치료24주시,용덕국SEQUOIAS-512형B초측정경동맥내막-중층후도(IMT);기록치료중출현적부작용등진행비교.결과 환자치료4주、12주、24주혈지시험발현,량개시험조중적LDL、TC、TG하강여공백조비교균유통계학의의(P<0.05);재치료24주후,량개시험조가사경동맥내막-중층후도감소(P<0.05);이차,불벌타정적부작용교소,3조간적차이몰유통계학의의(P>0.05).결론 불동제량불벌타정대결혈성뇌졸중환자적료효명현불동,월대제량적불벌타정대결혈성뇌졸중환자적LDL-L、TC강저작용월명현、대경동맥죽양경화발전적억제작용취월대,차부작용미견증가.량호적호리,능사환자보지교호적용약의종성、급조발현약물적부작용,종이보증치료적순리진행,촉진환자조일강복.
Objective To explore the effect and nursing main points of fluvastatin on the patients with cerebral arterial thrombosis. Methods Eighty-five patients with cerebral arterial thrombosis were randomly divided into three groups. Group Ⅰ was the negative control group. Group Ⅱ was the conventional-dose therapy group and group Ⅲ was the high-dose therapy group. Each group was treated with related therapy and care. The blood lipids in all groups were tested before the treatment, 4 weeks, 12 weeks and 24 weeks after the treatment; the carotid intima-media thickness (IMT) were measured by the Germany SEQUOIAS-512-B ultra machine before the treatment and 24 weeks after the treatment; At the same time, the side effects of fluvastatin were recorded. Results The results of blood lipid tests showed that the LDL, TC and TG in two treated groups were significantly decreased compared to negative control group (P<0.05). After treated for 24 weeks, the carotid intima-media thickness (IMT) in two treated groups were significantly reduced (P<0.05); the side effects of fluvastatin were infrequent and there was no significant different among the three groups (P>0.05). Conclusion The effects of different doses of fluvastatin on cerebral arterial thrombosis were significantly different. With the dose of fluvastatin increased, the serum LDL-L and TC reduced more obvious and the inhibition on carotid atherosclerosis shows more obvious, and the side effects did not increased.